Your session is about to expire
← Back to Search
Educating Providers About Lung Screening
N/A
Waitlist Available
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months post-randomization
Awards & highlights
No Placebo-Only Group
Summary
This trial tests two online training programs for doctors to improve their knowledge and practices regarding lung cancer screening. It focuses on primary care providers at MedStar and aims to see if adding health disparities information makes a difference. The effectiveness is measured through surveys and medical record reviews.
Eligible Conditions
- Lung Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months post-randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months post-randomization
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of providers with improved mean attitudes score
Number of providers with improved mean lung cancer screening knowledge score
Secondary study objectives
Rate of lung cancer screening referrals
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: LuCa + Health Disparity moduleExperimental Treatment1 Intervention
Participants will be asked to complete the Health Disparities module that is an interactive CME/CE online course which offers 0.5 continuing education credit hours.
The will also be asked to complete the LuCa course.
Group II: LuCa only moduleActive Control1 Intervention
LuCa is a free interactive CME/CE online course entitled, "Lung Cancer and the Primary Care Provider". For the purpose of this study, participants will be asked to complete session 1 which offers 1.0 continuing education credit hours, including AMA PRA Category 1 credits, AANP, and AAFP Prescribed credits.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LuCa + Health Disparity module
2021
N/A
~80
Find a Location
Who is running the clinical trial?
Georgetown UniversityLead Sponsor
350 Previous Clinical Trials
139,088 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,503 Total Patients Enrolled